Trials Sponsors Conditions Drugs Pricing

Conditions

Ischemic Stroke

Outcome Measures

Primary Outcomes (1)

Evaluation of the safety of Magneto Microcatheter in the acute post procedure duration by assessing the incidence of device related Serious Adverse Events within 24 hours post procedure
Occurrence of device related Serious Adverse Events
24 hours

Secondary Outcomes (2)

Evaluation of the safety of Magneto Microcatheter by assessing the incidence of device related Serious Adverse Events within 90 days post procedure
90 days
Evaluation of the performance of Magneto Microcatheter by assessing its ability to remove the clot and evaluating its ease of use
During Procedure

Study Arms (1)

Magneto Microcatheter

EXPERIMENTAL

Device: Magneto Microcatheter

Interventions

Magneto MicrocatheterDevice

All patients will be treated with Magneto Microcatheter

Magneto Microcatheter

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 85 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Clinical signs consistent with acute ischemic stroke
Patient with Acute Ischemic Stroke within 24 hours from symptoms o

Sponsors & Collaborators

Magneto Thrombectomy Solutions
Industrylead

Study Sites (3)

National Institute of Mental Health, Neurology and Neurosurgery)

Budapest, Hungary

Shaare Zedek

Jerusalem, Israel

Sheba Medical Center

Ramat Gan, Israel

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

Dr. Marzelik
Sheba Medical Center
PRINCIPAL INVESTIGATOR
Dr.Amsalem
Shaare Zedek, Israel
PRINCIPAL INVESTIGATOR

Enrollment

4 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: INDUSTRY
Responsible Party: SPONSOR

Study Record Dates

First Submitted

July 5, 2020

First Posted

July 10, 2020

Study Start

November 1, 2020

Actual (reported)

Evaluation of the Safety and Performance of Magneto Microcatheter

Brief Summary

Registry Overview

Trial Relationships

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

Magneto Microcatheter

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (3)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

First Submitted

First Posted

Study Start

Primary Completion

Study Completion

Conditions

Outcome Measures

Primary Outcomes (1)

Secondary Outcomes (2)

Study Arms (1)

Magneto Microcatheter

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (3)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

You may not qualify if:

Data Sharing

Source record

Locations